Placing transplanted insulin-producing cells in an insulating pouch removes the need for immunosuppressing drugs, and can provide people with type 1 diabetes with a treatment that removes the need for daily insulin injections. But this approach has encountered a problem: the formation of scar tissue around the implant, which impedes the cells’ work. A startup is working on “scarless pouch” technology. Read more